---
title: "Iloperidone - Schizophrenia"
sidebar: mydoc_sidebar
permalink: db04946-mesh-d012559-1.html
toc: false 
---


Path ID: `DB04946_MESH_D012559_1`
{% include image.html url="images/db04946-mesh-d012559-1.png" file="db04946-mesh-d012559-1.png" alt="db04946-mesh-d012559-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C081732 | Iloperidone | Drug |
| UniProt:P28223 | 5-hydroxytryptamine receptor 2A | Protein |
| UniProt:P21728 | D(1A) dopamine receptor | Protein |
| MESH:D004298 | Dopamine | ChemicalSubstance |
| HP:0000716 | Depressivity | PhenotypicFeature |
| GO:0061527 | Dopamine secretion, neurotransmission | BiologicalProcess |
| MESH:D012559 | Schizophrenia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Iloperidone | DECREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 2A |
| Iloperidone | DECREASES ACTIVITY OF | D(1A) Dopamine Receptor |
| 5-Hydroxytryptamine Receptor 2A | POSITIVELY CORRELATED WITH | Depressivity |
| Depressivity | MANIFESTATION OF | Schizophrenia |
| D(1A) Dopamine Receptor | POSITIVELY CORRELATED WITH | Dopamine |
| Dopamine | POSITIVELY CORRELATED WITH | Dopamine Secretion, Neurotransmission |
| Dopamine Secretion, Neurotransmission | POSITIVELY CORRELATED WITH | Schizophrenia |
|---------|-----------|---------|

Reference: 
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716179/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716179/)
  - [https://go.drugbank.com/drugs/DB04946](https://go.drugbank.com/drugs/DB04946)
